Here are most of our publications since January 2013.

2013

  • Zughaft, D., Bhiladvala, P., van Dijkman, A., Harnek, J., Hardig.B.M., Bjork, J., Ekelund,U. & ErlingeD. 2013. The analgesic effect of oxygen during percutaneous coronary intervention (The OXYPAIN Trial). Acute Cardiac Care 15(3): 63–68. http://informahealthcare.com/doi/pdfplus/10.3109/17482941.2013.822083
  • Tofik, R., Ekelund, U., Torffvit, O., Swärd, P., Rippe, B. & Bakoush, O. 2013. Increased urinary IgM excretion in patients with chest pain due to coronary artery disease. BMC Cardiovascular Disorders 2013, 13:72. http://www.biomedcentral.com/content/pdf/1471-2261-13-72.pdf
  • Carlsson, M., Jögi, J., Markenroth Bloch, K., Hedén, B., Ekelund, U., Ståhlberg, F. & Arheden,H. 2013. Submaximal adenosine induced coronary hyperemia with 12 hours caffeine abstinence; implications for clinical adenosine perfusion imaging tests. Clin Physiol Funct Imaging 2014 Jan 12. doi: 10.1111/cpf.12125. [Epub ahead of print]
  • Hofmann, R., James. S.K., Svensson, L., Witt, N., Frick, M., Lindahl, B., Östlund, O., Ekelund, U., Erlinge, D., Herlitz, J. & Jernberg, T. 2013. DETermination of the role of OXygen in Acute Myocardial Infarction (DETO₂X-AMI) trial. A prospective, multicenter, controlled, randomized, registry based clinical trial based on the SWEDEHEART registry. Study design, rationale and pilot study. Accepted, Am Heart J.
  • Gjesdal, G. & Ekelund, U. 2013. ABC om akut hjärtsvikt. Läkartidningen 109, 48, 2223-2226. http://www.lakartidningen.se/store/articlepdf/1/18934/LKT1248s2223_2226.pdf
  • Hallas, P., Ekelund, U., Björnsen, L-.P. & Brabrand, M. 2013. Hoping for a domino effect. A new specialty in Sweden is a breath of fresh air for the development of Scandinavian emergency medicine. Scand J Trauma, Resusc Emerg Med, 21:26. http://www.sjtrem.com/content/21/1/26
  • Sundblom E, Dryver E. 2013. ABC om beslutsfattande på akuten.  Läkartidningen 110:631-5.

2014

2015

2016